Age-Specific Determinants of Pulse Wave Velocity among Metabolic Syndrome Components, Inflammatory Markers, and Oxidative Stress
- PMID: 28740031
- PMCID: PMC5827087
- DOI: 10.5551/jat.39388
Age-Specific Determinants of Pulse Wave Velocity among Metabolic Syndrome Components, Inflammatory Markers, and Oxidative Stress
Abstract
Aim: Pulse wave velocity (PWV) is thought to have different relationships with metabolic syndrome (MS) components, inflammatory markers, and oxidative stress, according to age. However, age-specific determinants of PWV have not yet been studied. We investigated age-dependent relationships among PWV and MS components, inflammatory markers, and oxidative stress.
Methods: A total of 4,318 subjects were divided into 4 groups: 19-34 y (n=687), 35-44 y (n=1,413), 45-54 y (n=1,384), and 55-79 y (n=834). MS components, brachial-ankle PWV (baPWV), high-sensitivity C-reactive protein (hs-CRP), and oxidative stress markers were measured.
Results: There were age-related increases in MS, body mass index (BMI), waist circumference, systolic blood pressure (SBP), diastolic BP (DBP), triglycerides, glucose, hs-CRP, oxidized low-density lipoprotein (LDL), 8-epi-prostaglandin F2α (8-epi-PGF2α), and baPWV. BaPWV was significantly associated with sex and elevated BP in the 19-34 y group; with age, sex, BMI, elevated BP and triglycerides in the 35-44 y group; with age, sex, elevated BP, fasting glucose, hs-CRP and oxidized LDL in the 45-54 y group; and with age, BMI, elevated BP, fasting glucose and oxidized LDL in the 55-79 y group.
Conclusions: Our results show that age-related increases in baPWV are associated with age-related changes in MS components, inflammatory markers, and oxidative stress. However, each of these factors has an age-specific, different impact on arterial stiffness. In particular, oxidative stress may be independently associated with arterial stiffness in individuals older than 45 y.
Keywords: Arterial stiffness; Metabolic syndrome; Oxidative stress; baPWV.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
References
-
- Expert Panel on Detection: Executive summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA, 2001; 285: 2486-2497 - PubMed
-
- Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group : The metabolic syndrome--a new worldwide definition. Lancet, 2005; 366: 1059-1062 - PubMed
-
- Aguilar D, Fisher MR, O'Connor CM, Dunne MW, Muhlestein JB, Yao L, Gupta S, Benner RJ, Cook TD, Edwards D, Pfeffer MA, Investigators in the Weekly Intervention with Zithromax for Atherosclerosis and its Related Disorder study : metabolic syndrome, C-reactive protein, and prognosis in patients with established coronary artery disease. Am Heart J, 2006; 152: 298-304 - PubMed
-
- Kim S-H, Ji S-H, Park Y-M, Cho K-H: The relationship of the prevalence metabolic syndrome and the difference of life style in Korean adult. Korean J Fam Pract, 2015; 5: 500-509
-
- Mure K, Yoshimura N, Hashimoto M, Muraki S, Oka H, Tanaka S, Kawaguchi H, Nakamura K, Akune T, Takeshita T: Urinary 8-iso-prostaglandin F2α as a marker of metabolic risks in the general Japanese population: the ROAD study. Obesity (Silver Spring), 2015; 23: 1517-1524 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
